Candel Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
Trinity Capital Inc. (TRIN)
US:NASDAQ Investor Relations:
lanb.com/home/about-us/news/2017/09/15/trinity-capital-corporation-commences-trading-on-otcqx-and-announces-dtc-eligibility
Company Research
Source: Yahoo! Finance
patients with progressive, metastatic, non-squamous, non-small cell lung cancer (NSCLC) despite immune checkpoint inhibitor (ICI) treatment, in Q2 2026 Company plans to submit a Biologics License Application (BLA) for aglatimagene in localized, intermediate-to high-risk prostate cancer in Q4 2026 Company announced investigational new drug (IND) clearance for linoserpaturev (CAN-3110) in recurrent high-grade glioma (rHGG) to support enabling work for a potential future randomized controlled phase 2 dose regimen finding study. Entered into a $130 million term loan facility with Trinity Capital Inc. (Trinity Capital) with $50 million drawn down at closing, and access of up to an additional $80 million Cash and cash equivalents of $119.7 million, as of December 31, 2025, together with $93.5 million in net proceeds from the February 2026 follow-on equity offering, strengthens the Company's financial position and is sufficient to fund the current operating plan into Q1 2028, which i
Show less
Read more
Impact Snapshot
Event Time:
TRIN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TRIN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TRIN alerts
High impacting Trinity Capital Inc. news events
Weekly update
A roundup of the hottest topics
TRIN
News
- Trinity Capital Provides $50 Million in Growth Capital to Sage Health to Expand Senior-Focused Primary Care Wellness CentersPR Newswire
- Does Trinity's New Lower Middle-Market Lending Venture and Steady Dividends Change The Bull Case For Trinity Capital (TRIN)? [Yahoo! Finance]Yahoo! Finance
- Trinity Capital: BDC Turning Asset Manager Provides Strong Yield And Better Value [Seeking Alpha]Seeking Alpha
- Trinity Capital – A 14% BDC Roller Coaster [Yahoo! Finance]Yahoo! Finance
- Trinity Capital (TRIN) was downgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=TRIN&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "hold" MarketBeat
TRIN
Earnings
- 2/25/26 - In-Line
TRIN
Analyst Actions
- 1/27/26 - Citigroup Inc.
TRIN
Sec Filings
- 3/17/26 - Form 4
- 3/17/26 - Form 4
- 3/17/26 - Form 4
- TRIN's page on the SEC website